Register entry

Protalix Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Live patents
0
Countries
1
Base
Israel
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Protalix Ltd2 Snunit St. Science Park, POB 455, Carmiel, 2161401, Israel (ISR)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3008289067600721419
Catalogue

Drug listings by form and route

2

2 active NDC listings: 1 bulk ingredient, 1 drug for further processing. By marketing category: BULK INGREDIENT 1, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
injection, powder, for solution1
liquid1
RouteNDCs
Labeller name on the listingNDCs
protalix ltd2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Taliglucerase alfainjection, powder, for solution50210-248BULK INGREDIENT
-Taliglucerase alfaliquid50210-249DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in Israel

Enquiry

Common questions

Is Protalix Ltd FDA approved?
Protalix Ltd holds 1 FDA-registered establishment in Israel. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Protalix Ltd's drugs manufactured?
The FDA register lists Carmiel. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
What drugs does Protalix Ltd make?
2 products are listed under Protalix Ltd in the openFDA NDC Directory, most often as injection, powder, for solution; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.